Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Advanced Medical Solutions Group stock

AMS.L
GB0004536594
905598

Price

0 GBP
Today +/-
-0 GBP
Today %
-0 %

Advanced Medical Solutions Group stock price

GBP
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Advanced Medical Solutions Group stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Advanced Medical Solutions Group stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Advanced Medical Solutions Group stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Advanced Medical Solutions Group's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Advanced Medical Solutions Group Stock Price History

DateAdvanced Medical Solutions Group Price
1/20/20250 GBP
1/17/20252.21 GBP
1/16/20252.28 GBP
1/15/20252.25 GBP
1/14/20252.18 GBP
1/13/20251.91 GBP
1/10/20251.91 GBP
1/9/20251.93 GBP
1/8/20251.90 GBP
1/7/20251.95 GBP
1/6/20251.93 GBP
1/3/20251.92 GBP
1/2/20251.97 GBP
12/31/20241.98 GBP
12/30/20241.97 GBP
12/27/20241.98 GBP
12/24/20241.99 GBP
12/23/20241.97 GBP

Advanced Medical Solutions Group Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Advanced Medical Solutions Group, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Advanced Medical Solutions Group from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Advanced Medical Solutions Group’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Advanced Medical Solutions Group. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Advanced Medical Solutions Group’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Advanced Medical Solutions Group’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Advanced Medical Solutions Group’s growth potential.

Advanced Medical Solutions Group Revenue, EBIT and net profit per share

DateAdvanced Medical Solutions Group RevenueAdvanced Medical Solutions Group EBITAdvanced Medical Solutions Group Net Income
2029e300.12 M GBP0 GBP0 GBP
2028e285.17 M GBP0 GBP0 GBP
2027e274.97 M GBP47.72 M GBP36.06 M GBP
2026e251.23 M GBP44.08 M GBP33.03 M GBP
2025e236.64 M GBP40.41 M GBP28.67 M GBP
2024e183.57 M GBP30.29 M GBP24.55 M GBP
2023126.21 M GBP18.88 M GBP15.89 M GBP
2022124.33 M GBP24.89 M GBP20.41 M GBP
2021108.6 M GBP23 M GBP17.48 M GBP
202086.8 M GBP11.56 M GBP8.58 M GBP
2019102.37 M GBP25.3 M GBP18.92 M GBP
2018102.6 M GBP28.88 M GBP22.49 M GBP
201796.91 M GBP25.24 M GBP20.13 M GBP
201683.24 M GBP19.47 M GBP15.69 M GBP
201568.6 M GBP17.04 M GBP14.12 M GBP
201463.01 M GBP15.17 M GBP12.86 M GBP
201359.5 M GBP13.7 M GBP11.4 M GBP
201252.6 M GBP12.3 M GBP9.7 M GBP
201134.4 M GBP6.4 M GBP4.9 M GBP
201031.9 M GBP5.3 M GBP4.8 M GBP
200924.1 M GBP4.2 M GBP2.8 M GBP
200820.3 M GBP2.6 M GBP3.3 M GBP
200716.9 M GBP1.7 M GBP2.2 M GBP
200614.3 M GBP400,000 GBP700,000 GBP
200512.9 M GBP0 GBP300,000 GBP
200411 M GBP-1.1 M GBP-400,000 GBP

Advanced Medical Solutions Group Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M GBP)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M GBP)NET INCOME (M GBP)NET INCOME GROWTH (%)DIV. (GBP)DIV. GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
567789111214162024313452596368839610210286108124126183236251274285300
-20.0016.67-14.2912.5022.229.0916.6714.2925.0020.0029.179.6852.9413.466.787.9422.0615.666.25--15.6925.5814.811.6145.2428.966.369.164.015.26
1,400.001,166.671,000.0014.2925.0033.3336.3641.6742.8643.7545.0045.8345.1647.0653.8557.6355.5657.3557.8360.4261.7658.8253.4956.4858.8755.5638.2529.6627.8925.5524.5623.33
00012345679111416283435394858636046617370000000
-4-5-2-1-1-20002324491112141520221881720152428333600
-25.00-60.00-50.00-100.00----50.00-33.33100.00-125.0022.229.0916.677.1433.3310.00-18.18-55.56112.5017.65-25.0060.0016.6717.869.09--
--------------------------------
--------------------------------
61.293.693.293.6126.1142.1142.1142.9146.1151.2153.3155.4154.9159.6208208.7211.52211.28212.59214.32216.06216.84217.83218.31219.48219.29000000
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Advanced Medical Solutions Group Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Advanced Medical Solutions Group is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M GBP)RECEIVABLES (M GBP)OTHER REC. (M GBP)INVENTORIES (M GBP)OTHER CURRENT LIAB. (M GBP)CURRENT ASSETS (M GBP)TANGIBLE ASSETS (M GBP)LONG-T. INVEST. (M GBP)LONG-T. REC. (k GBP)INTANGIBLE ASSETS (M GBP)GOODWILL (M GBP)OTHER NON-CURRENT ASSETS (M GBP)NON-CURRENT ASSETS (M GBP)TOTAL ASSETS (M GBP)LIABILITIESCOMMON STOCK (M GBP)ADDITIONAL PAID-IN CAPITAL (M GBP)RETAINED EARNINGS (M GBP)OTHER EQUITY (M GBP)UNREAL. GAINS/LOSSES (M GBP)EQUITY (M GBP)LIABILITIES (M GBP)PROVISIONS (M GBP)OTHER SHORT-TERM LIAB. (M GBP)SHORT-TERM DEBTS (M GBP)LONG-TERM DEBT PORTION (M GBP)SHORT-TERM REC. (M GBP)LONG-T. LIAB. (M GBP)DEFERRED TAXES (M GBP)OTHER LIAB. (M GBP)LONG-T. LIABILITIES (M GBP)DEBT (M GBP)TOTAL CAPITAL (M GBP)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                   
7.42.776.25.63.63.23.44.67.57.624.17.18.95.317.2834.251.1362.4576.3964.7553.8372.9782.2660.16
1.41.61.81.51.822.73.342.63.75.65.39.69.210.310.859.3810.4619.0424.6625.6317.6617.5217.7120.91
0.50.30.50.40.60.60.40.30.40.40.30.80.31.10.310.020.050.690.231.511.41.843.382.691.77
2.41.810.90.91.31.51.71.81.72.23.22.56.76.587.538.8411.4411.0714.817.6621.0319.327.9136.05
0.20.10.30.20.30.30.30.40.30.50.91.40.50.80.91.21.191.41.161.721.822.332.821.811.343.44
11.96.510.69.29.27.88.19.111.112.714.71312.725.325.825.836.8753.8774.8794.52119.18111.7697.18114.97131.91122.32
65.65.44.84.94.43.73.42.92.93.210.312.81717.616.71615.816.1817.0227.8527.7130.0627.4429.0229.6
00000000001.7000000000000000
00000000020090000000141310005310000
00002.42.22.11.91.72221.814.413.213.612.9212.1713.6114.8915.4333.3342.0440.9648.3755.86
0000000000032.939.338.439.336.734.5840.3441.842.1553.5668.9166.0370.8680.44
0000000001.421.62.83.52.71.71.110.1400.490.620.10.360.110.940.95
65.65.44.87.36.65.85.34.66.59.816.920.374.271.971.366.7462.6970.1474.1986.04115.23141.38134.54149.18166.85
17.912.1161416.514.413.914.415.719.224.529.93399.597.797.1103.62116.56145.01168.72205.22226.98238.56249.51281.09289.17
                                                   
6.26.29.49.411.811.811.811.811.87.27.27.27.710.210.210.310.3910.4510.5210.6310.6710.7510.7710.810.8410.87
33.633.636.936.93838383838000.10.331.731.932.432.7433.234.0134.7835.1936.2336.293737.2737.47
-25-30.1-32.8-34.3-35.7-37.8-38.2-37.9-37.18.612.315.319.924.533.143.555.4668.984.05103.7126.13144.12150.82167185.19198.86
00000000000.40.2-0.1-0.1-1.40-5.39-8.74-2.93.480.880.314.5-1.963.493.88
00000000000000000000000000
14.89.713.51214.11211.611.912.715.819.922.827.866.373.886.293.2103.81125.68152.59172.88191.39202.37212.84236.79251.08
1.31.31.10.911.51.21.31.51.51.92.51.63.52.72.42.383.343.282.583.967.46.794.886.426.23
0.80.60.80.60.60.40.40.50.81.21.331.61.92.12.82.853.915.425.926.33.184.216.416.713.92
0.10.10.10.20.20.30.20.30.30.51.10.813.51.32.62.632.936.344.368.255.252.464.578.4910.27
00000000000000000000000000
0.50.30.20.10.10000000022.8000000.981.351.261.151.061.16
2.72.32.21.81.92.21.82.12.63.24.36.34.210.98.97.87.8610.1815.0412.8519.4817.1814.7217.0122.6821.58
0.40.10.20.1000000.30.30.30.218.511.6000009.069.019.868.718.697.97
00000000000003.42.82.82.512.313.153.123.36.418.547.449.5911.01
00.20.20.10.50.30.40.30.3000.30.70.60.60.50.470.421.290.310.663.153.233.683.514.4
0.40.30.40.20.50.30.40.30.30.30.30.60.922.5153.32.992.734.443.4313.0118.5721.6319.8221.7923.39
3.12.62.622.42.52.22.42.93.54.66.95.133.423.911.110.8512.9119.4816.2832.4935.7536.3436.8344.4744.97
17.912.316.11416.514.513.814.315.619.324.529.732.999.797.797.3104.05116.72145.16168.87205.38227.14238.72249.67281.26296.05
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Advanced Medical Solutions Group provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Advanced Medical Solutions Group's financial health and stability.

Assets

Advanced Medical Solutions Group's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Advanced Medical Solutions Group must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Advanced Medical Solutions Group after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Advanced Medical Solutions Group's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M GBP)DEPRECIATION (M GBP)DEFERRED TAXES (M GBP)CHANGES IN WORKING CAPITAL (M GBP)NON-CASH ITEM (M GBP)PAID INTEREST (M GBP)PAID TAXES (M GBP)NET CASH FLOW FROM OPERATING ACTIVITIES (M GBP)CAPITAL EXPENDITURES (M GBP)CASH FLOW FROM INVESTING ACTIVITIES (M GBP)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M GBP)INTEREST INCOME AND EXPENSES (M GBP)NET DEBT CHANGE (M GBP)NET CHANGE IN EQUITY (M GBP)CASH FLOW FROM FINANCING ACTIVITIES (M GBP)CASH FLOW FROM OTHER FINANCING ACTIVITIES (GBP)TOTAL DIVIDENDS PAID (M GBP)NET CHANGE IN CASH FLOW (M GBP)FREE CASH FLOW (M GBP)SHARE-BASED COMPENSATION (M GBP)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-6-5-3-1-1-2-10012244111315171925282410222418
000001110010112222224568810
00000000000000000000000000
0000000001-1-11-1-2-2-10-3-12-12-102-2-9-20
00000000000000000011111122
00000000000000000000000000
00000000000000001124353434
-4-3-100-100132274111416211916212121312612
0000000000-1-7-3-2-2-2-2-2-2-4-4-5-5-6-9-9
-73-50-2100-1-3-1-2-5-55-2-2-2-2-2-4-4-29-26-6-11-20
-64-41-22000-205-1-530000000-23-210-1-10
00000000000000000000000000
-100000000000020-5-14000000-1-1-1-1
110704000000003300000001000-6
806030000000053-7-15-1-1-1-1-3-3-5-5-6-13
--------------------------
000000000000000-1-1-1-1-2-2-3-3-3-4-4
-300000000010231-31216161113-11-10199-22
-5.61-4.21-1.95-0.75-1.15-1.83-0.420.241.162.861.52-53.22.389.141214.1118.5417.2512.2516.9215.8516.2524.5616.912.5
00000000000000000000000000

Advanced Medical Solutions Group stock margins

The Advanced Medical Solutions Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Advanced Medical Solutions Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Advanced Medical Solutions Group.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Advanced Medical Solutions Group's sales revenue. A higher gross margin percentage indicates that the Advanced Medical Solutions Group retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Advanced Medical Solutions Group's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Advanced Medical Solutions Group's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Advanced Medical Solutions Group's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Advanced Medical Solutions Group. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Advanced Medical Solutions Group's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Advanced Medical Solutions Group Margin History

Advanced Medical Solutions Group Gross marginAdvanced Medical Solutions Group Profit marginAdvanced Medical Solutions Group EBIT marginAdvanced Medical Solutions Group Profit margin
2029e55.57 %0 %0 %
2028e55.57 %0 %0 %
2027e55.57 %17.36 %13.11 %
2026e55.57 %17.55 %13.15 %
2025e55.57 %17.08 %12.12 %
2024e55.57 %16.5 %13.37 %
202355.57 %14.96 %12.59 %
202259.05 %20.02 %16.41 %
202156.23 %21.18 %16.1 %
202053.04 %13.32 %9.89 %
201959.08 %24.71 %18.48 %
201861.8 %28.14 %21.92 %
201760.27 %26.05 %20.78 %
201657.72 %23.38 %18.85 %
201558.18 %24.84 %20.58 %
201456.88 %24.08 %20.42 %
201357.65 %23.03 %19.16 %
201254.37 %23.38 %18.44 %
201147.09 %18.6 %14.24 %
201046.08 %16.61 %15.05 %
200948.13 %17.43 %11.62 %
200848.28 %12.81 %16.26 %
200743.79 %10.06 %13.02 %
200641.96 %2.8 %4.9 %
200539.53 %0 %2.33 %
200437.27 %-10 %-3.64 %

Advanced Medical Solutions Group Stock Sales Revenue, EBIT, Earnings per Share

The Advanced Medical Solutions Group earnings per share therefore indicates how much revenue Advanced Medical Solutions Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Advanced Medical Solutions Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Advanced Medical Solutions Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Advanced Medical Solutions Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Advanced Medical Solutions Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Advanced Medical Solutions Group Revenue, EBIT and net profit per share

DateAdvanced Medical Solutions Group Sales per ShareAdvanced Medical Solutions Group EBIT per shareAdvanced Medical Solutions Group Earnings per Share
2029e1.38 GBP0 GBP0 GBP
2028e1.31 GBP0 GBP0 GBP
2027e1.26 GBP0 GBP0.17 GBP
2026e1.15 GBP0 GBP0.15 GBP
2025e1.09 GBP0 GBP0.13 GBP
2024e0.84 GBP0 GBP0.11 GBP
20230.58 GBP0.09 GBP0.07 GBP
20220.57 GBP0.11 GBP0.09 GBP
20210.5 GBP0.11 GBP0.08 GBP
20200.4 GBP0.05 GBP0.04 GBP
20190.47 GBP0.12 GBP0.09 GBP
20180.47 GBP0.13 GBP0.1 GBP
20170.45 GBP0.12 GBP0.09 GBP
20160.39 GBP0.09 GBP0.07 GBP
20150.32 GBP0.08 GBP0.07 GBP
20140.3 GBP0.07 GBP0.06 GBP
20130.29 GBP0.07 GBP0.05 GBP
20120.25 GBP0.06 GBP0.05 GBP
20110.22 GBP0.04 GBP0.03 GBP
20100.21 GBP0.03 GBP0.03 GBP
20090.16 GBP0.03 GBP0.02 GBP
20080.13 GBP0.02 GBP0.02 GBP
20070.11 GBP0.01 GBP0.01 GBP
20060.1 GBP0 GBP0 GBP
20050.09 GBP0 GBP0 GBP
20040.08 GBP-0.01 GBP-0 GBP

Advanced Medical Solutions Group business model

Advanced Medical Solutions Group PLC (AMS) is a leading British manufacturer of medical products and technologies for wound care, hemorrhoid treatment, and tissue engineering. The company was founded in 1991 and is headquartered in Winsford, Cheshire. The company's history began with the discovery of an innovative skin adhesive by founder Chris Meredith. This adhesive was later introduced to the market as LiquiBand® and revolutionized wound care as it was quick and easy to use, eliminating the need for sutures, staples, or stitches. Since then, the company has continuously expanded its product range and operates in three main areas: wound care, hemorrhoid treatment, and tissue engineering. In the field of wound care, AMS offers a wide range of products for the treatment of acute and chronic wounds. This includes the aforementioned skin adhesive LiquiBand®, silicone films to prevent scarring, dressings for chronic wounds such as HydroAktiv® and Silflex®, as well as a specialized vacuum therapy device called Versajet®. In the field of hemorrhoid treatment, AMS has developed an innovative technology called Hemoclear®, which enables quick and painless treatment of hemorrhoids. This technology uses focused light to disrupt the blood supply to the hemorrhoids and eventually cut them off without causing pain or bleeding. In the field of tissue engineering, AMS collaborates closely with leading medical institutions and research facilities to develop new technologies for tissue regeneration. This includes artificial bone material and biological adhesives for use in neurosurgery. AMS' business model is based on the development and commercialization of innovative medical products and technologies. The company aims to stay at the forefront of medical research and technology to provide the best products that meet the needs of patients and healthcare professionals. AMS also has a strong focus on research and development to continuously develop new products and improve existing ones. AMS operates internationally and distributes its products throughout Europe, as well as in North America, South America, Asia, and Australia. The company is part of the FTSE AIM All-Share Index and has a strong financial position with a revenue of £112.1 million in 2019 and a gross profit of £79.3 million. In summary, Advanced Medical Solutions Group PLC is a leading British manufacturer of medical products and technologies for wound care, hemorrhoid treatment, and tissue engineering. The company is dedicated to the development and commercialization of innovative products and collaborates closely with healthcare professionals and institutions to provide the best treatment for patients. AMS has a strong international presence and a solid financial position, allowing it to maintain its focus on research and development and continuously develop new products. Advanced Medical Solutions Group is one of the most popular companies on Eulerpool.com.

Advanced Medical Solutions Group SWOT Analysis

Strengths

Advanced Medical Solutions Group PLC has several strengths that contribute to its success in the market. These include:

  • Strong portfolio of innovative medical products and solutions
  • Robust research and development capabilities
  • Well-established distribution network
  • Highly skilled and experienced workforce
  • Strong brand reputation and recognition

Weaknesses

Despite its strengths, Advanced Medical Solutions Group PLC also faces certain weaknesses, such as:

  • Dependency on a limited number of suppliers
  • Relatively small market presence compared to larger competitors
  • Vulnerability to fluctuations in the healthcare industry
  • Limited geographical reach

Opportunities

There are several opportunities that Advanced Medical Solutions Group PLC can capitalize on, including:

  • Increasing global demand for advanced medical solutions
  • Expansion into emerging markets with growing healthcare needs
  • Potential partnerships and collaborations to leverage complementary expertise
  • Advancements in technology opening up new possibilities for medical solutions

Threats

Despite its strengths and opportunities, Advanced Medical Solutions Group PLC faces certain threats that could impact its performance. These threats include:

  • Intense competition from larger and more established players
  • Evolving regulatory landscape and compliance requirements
  • Rapidly changing market dynamics and customer preferences
  • Potential disruptions in the global supply chain
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Advanced Medical Solutions Group Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Advanced Medical Solutions Group historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Advanced Medical Solutions Group shares outstanding

The number of shares was Advanced Medical Solutions Group in 2024 — This indicates how many shares 219.289 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Advanced Medical Solutions Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Advanced Medical Solutions Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Advanced Medical Solutions Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Advanced Medical Solutions Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Advanced Medical Solutions Group dividend history and estimates

In 2024, Advanced Medical Solutions Group paid a dividend amounting to 0.02 GBP. Dividend means that Advanced Medical Solutions Group distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Advanced Medical Solutions Group provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Advanced Medical Solutions Group’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Advanced Medical Solutions Group's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Advanced Medical Solutions Group Dividend History

DateAdvanced Medical Solutions Group Dividend
2029e0.02 GBP
2028e0.02 GBP
2027e0.02 GBP
2026e0.02 GBP
2025e0.02 GBP
2024e0.02 GBP
20230.02 GBP
20220.02 GBP
20210.02 GBP
20200.02 GBP
20190.01 GBP
20180.01 GBP
20170.01 GBP
20160.01 GBP
20150.01 GBP
20140.01 GBP
20130.01 GBP
20120.01 GBP
20110.01 GBP

Advanced Medical Solutions Group dividend payout ratio

In 2024, Advanced Medical Solutions Group had a payout ratio of 23.86%. The payout ratio indicates the percentage of the company's profits that Advanced Medical Solutions Group distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Advanced Medical Solutions Group represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Advanced Medical Solutions Group could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Advanced Medical Solutions Group's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Advanced Medical Solutions Group Payout Ratio History

DateAdvanced Medical Solutions Group Payout ratio
2029e24.87 %
2028e24.75 %
2027e24.53 %
2026e25.33 %
2025e24.4 %
2024e23.86 %
202327.73 %
202221.62 %
202122.23 %
202039.33 %
201916.05 %
201811.24 %
201710.33 %
201611.52 %
201512.14 %
201411.51 %
201312 %
201210.56 %
201119.44 %
201027.73 %
200927.73 %
200827.73 %
200727.73 %
200627.73 %
200527.73 %
200427.73 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Advanced Medical Solutions Group.

Advanced Medical Solutions Group latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
12/31/20230.05 GBP0.04 GBP (-2.43 %)2023 Q4
12/31/20220.06 GBP0.05 GBP (-6.98 %)2022 Q4
12/31/20210.05 GBP0.05 GBP (-6.34 %)2021 Q4
12/31/20200.03 GBP0.03 GBP (4.79 %)2020 Q4
6/30/20200.02 GBP0.02 GBP (4.35 %)2020 Q2
12/31/20190.05 GBP0.05 GBP (-5.63 %)2019 Q4
6/30/20190.05 GBP0.05 GBP (-0.62 %)2019 Q2
12/31/20180.05 GBP0.06 GBP (2.42 %)2018 Q4
12/31/20170.05 GBP0.05 GBP (4.89 %)2017 Q4
6/30/20170.04 GBP0.04 GBP (7.48 %)2017 Q2
1
2
3

Eulerpool ESG Scorecard© for the Advanced Medical Solutions Group stock

Eulerpool World ESG Rating (EESG©)

53/ 100

🌱 Environment

42

👫 Social

71

🏛️ Governance

46

Environment

Scope 1 - Direct Emissions
1,342
Scope 2 - Indirect emissions from purchased energy
1,344
Scope 3 - Indirect emissions within the value chain
50,503
Total CO₂ emissions
2,686
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees45
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Advanced Medical Solutions Group shareholders

%
Name
Stocks
Change
Date
12.97226 % Octopus Investments Limited28,261,37117,98110/17/2024
9.56132 % Rathbone Unit Trust Management Limited20,830,283296,9224/30/2024
7.96523 % Canaccord Genuity Wealth Management17,353,049101,6674/30/2024
4.85527 % Charles Stanley & Co. Limited10,577,68548,0114/30/2024
4.04474 % INVESCO Asset Management Limited8,811,87231,2724/30/2024
3.00596 % AXA Investment Managers UK Ltd.6,548,77604/30/2024
2.08370 % Rathbones Investment Management Limited4,539,551393,8597/1/2024
1.98181 % Chelverton Asset Management Ltd.4,317,56807/31/2024
1.71462 % Royal London Asset Management Ltd.3,735,469260,4697/1/2024
1.46883 % Advanced Medical Solutions Group PLC Employee Benefit Trust3,200,0003,200,00012/31/2023
1
2
3
4
5
...
10

Advanced Medical Solutions Group Executives and Management Board

Mr. Andrew Meredith

Advanced Medical Solutions Group Chief Executive Officer, Executive Director (since 2005)
Compensation 832,000 GBP

Mr. Eddie Johnson

Advanced Medical Solutions Group Chief Financial Officer, Executive Director (since 2012)
Compensation 412,000 GBP

Mr. Peter Allen

(67)
Advanced Medical Solutions Group Non-Executive Independent Chairman of the Board
Compensation 94,000 GBP

Mr. Grahame Cook

(65)
Advanced Medical Solutions Group Senior Independent Non-Executive Director
Compensation 53,000 GBP

Mr. Douglas Le Fort

Advanced Medical Solutions Group Non-Executive Independent Director
Compensation 48,000 GBP
1
2
3

Most common questions regarding Advanced Medical Solutions Group

What values and corporate philosophy does Advanced Medical Solutions Group represent?

Advanced Medical Solutions Group PLC is a leading provider of innovative solutions for advanced wound care and surgical dressings. The company's values revolve around excellence, integrity, and collaboration. Advanced Medical Solutions is dedicated to delivering high-quality products that improve patient outcomes and enhance healthcare professionals' efficiency. Their corporate philosophy is centered on customer-centricity, continuous innovation, and a commitment to clinical evidence and compliance. With a strong focus on research and development, Advanced Medical Solutions strives to stay at the forefront of the industry, offering cutting-edge solutions that meet the evolving needs of healthcare providers and patients worldwide.

In which countries and regions is Advanced Medical Solutions Group primarily present?

Advanced Medical Solutions Group PLC is primarily present in multiple countries and regions across the globe. The company operates in various key markets, including the United Kingdom, Germany, the United States, and Australia. With a global presence, Advanced Medical Solutions Group PLC delivers its innovative medical technologies and products to healthcare professionals and patients worldwide. This allows the company to provide advanced solutions and address the needs of medical professionals across different geographies, ensuring enhanced patient care and improved healthcare outcomes.

What significant milestones has the company Advanced Medical Solutions Group achieved?

Advanced Medical Solutions Group PLC has achieved several significant milestones in its history. The company has successfully developed and commercialized innovative medical solutions, establishing itself as a global leader in advanced wound care and surgical products. Advanced Medical Solutions Group PLC has expanded its product portfolio, introducing new and improved technologies to address various medical needs. The company has also expanded its international presence, entering new markets and strengthening its position in existing ones. Furthermore, Advanced Medical Solutions Group PLC has shown consistent financial growth, demonstrating its ability to deliver value to its shareholders.

What is the history and background of the company Advanced Medical Solutions Group?

Advanced Medical Solutions Group PLC is a leading medical technology company specializing in the development and manufacturing of innovative wound care and surgical products. Founded in 1991, Advanced Medical Solutions has quickly grown to become a global leader in its field. The company is known for its expertise in adhesive technology and its commitment to developing high-quality, cost-effective solutions for healthcare professionals. With a strong focus on research and development, Advanced Medical Solutions continues to expand its portfolio of products and services to address the evolving needs of the medical community. Through strategic partnerships and acquisitions, the company has established a strong presence in key markets worldwide, driving its growth and success.

Who are the main competitors of Advanced Medical Solutions Group in the market?

The main competitors of Advanced Medical Solutions Group PLC in the market include Johnson & Johnson, 3M Company, and Smith & Nephew.

In which industries is Advanced Medical Solutions Group primarily active?

Advanced Medical Solutions Group PLC is primarily active in the healthcare industry.

What is the business model of Advanced Medical Solutions Group?

The business model of Advanced Medical Solutions Group PLC revolves around developing and manufacturing innovative and advanced wound care products and surgical dressings. The company specializes in creating solutions that promote faster wound healing and reduce infection risks for patients. Advanced Medical Solutions Group PLC also provides healthcare professionals with training and education services to ensure the effective and safe use of their products. With a focus on quality and research, the company aims to improve patient outcomes and enhance healthcare standards worldwide. Advanced Medical Solutions Group PLC continues to expand its product portfolio and collaborate with healthcare providers to address unmet medical needs.

What is the P/E ratio of Advanced Medical Solutions Group 2025?

The P/E ratio cannot be calculated for Advanced Medical Solutions Group at the moment.

What is the P/S ratio of Advanced Medical Solutions Group 2025?

The P/S cannot be calculated for Advanced Medical Solutions Group currently.

What is the Quality Investing of Advanced Medical Solutions Group?

The Quality Investing for Advanced Medical Solutions Group is 6/10.

What is the revenue of Advanced Medical Solutions Group 2025?

The expected Advanced Medical Solutions Group revenue is 236.64 M GBP.

How high is the profit of Advanced Medical Solutions Group 2025?

The expected Advanced Medical Solutions Group profit is 28.67 M GBP.

What is the business model of Advanced Medical Solutions Group

The Advanced Medical Solutions Group PLC is a global provider of innovative medical products and solutions that help improve patient care and optimize treatment outcomes. The company operates in three business areas: Woundcare, Surgical, and Advanced Wound Closure. In the Woundcare area, AMS offers a wide range of wound care products, including hydrocolloid, foam, silicone, and alginates, to ensure optimal treatment of chronic and acute wounds. AMS products are used in hospitals, clinics, and care facilities worldwide, helping to reduce healthcare costs and improve patients' quality of life. AMS Surgical specializes in surgical products, particularly innovative suture materials. The company offers a broad spectrum of suture materials, including absorbable, non-absorbable, and knotless sutures, designed to ensure optimal wound healing. These products are used in general surgery, cardiac surgery, orthopedics, and urology. The third business area of AMS is Advanced Wound Closure, which offers one of its most well-known products, TissuePatchDural. TissuePatchDural is a synthetic patch that facilitates brain surgery by lining the dura mater from the inside. It is easier and faster to apply than traditional suture techniques and provides better results. The company follows a highly effective business model based on innovative products accompanied by a customer-centric approach. AMS has made significant investments in research and development of new products and has an impressive product range that allows it to effectively meet customer needs. Another important factor is geographical diversification with branches in many countries, enabling AMS to benefit from diverse growth opportunities in various ways. In recent years, AMS has also made a series of acquisitions to further diversify its products and solutions and strengthen its market position. For example, in 2019, AMS acquired Heftds Healthcare Group plc, a company specialized in the development of surgical products, to expand the range of products. Overall, AMS's business model has repeatedly proven its strength over the years. The company is able to thrive in a challenging market environment and achieve operational and financial excellence. AMS will continue to play an important role in healthcare and can rely on growth opportunities due to its strong portfolio of innovative products and solutions.

What is the Advanced Medical Solutions Group dividend?

Advanced Medical Solutions Group pays a dividend of 0.02 GBP distributed over payouts per year.

How often does Advanced Medical Solutions Group pay dividends?

The dividend cannot currently be calculated for Advanced Medical Solutions Group or the company does not pay out a dividend.

What is the Advanced Medical Solutions Group ISIN?

The ISIN of Advanced Medical Solutions Group is GB0004536594.

What is the Advanced Medical Solutions Group WKN?

The WKN of Advanced Medical Solutions Group is 905598.

What is the Advanced Medical Solutions Group ticker?

The ticker of Advanced Medical Solutions Group is AMS.L.

How much dividend does Advanced Medical Solutions Group pay?

Over the past 12 months, Advanced Medical Solutions Group paid a dividend of 0.02 GBP . This corresponds to a dividend yield of about . For the coming 12 months, Advanced Medical Solutions Group is expected to pay a dividend of 0.02 GBP.

What is the dividend yield of Advanced Medical Solutions Group?

The current dividend yield of Advanced Medical Solutions Group is .

When does Advanced Medical Solutions Group pay dividends?

Advanced Medical Solutions Group pays a quarterly dividend. This is distributed in the months of June, October, June, October.

How secure is the dividend of Advanced Medical Solutions Group?

Advanced Medical Solutions Group paid dividends every year for the past 0 years.

What is the dividend of Advanced Medical Solutions Group?

For the upcoming 12 months, dividends amounting to 0.02 GBP are expected. This corresponds to a dividend yield of 1.06 %.

In which sector is Advanced Medical Solutions Group located?

Advanced Medical Solutions Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Advanced Medical Solutions Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Advanced Medical Solutions Group from 10/25/2024 amounting to 0.008 GBP, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did Advanced Medical Solutions Group pay the last dividend?

The last dividend was paid out on 10/25/2024.

What was the dividend of Advanced Medical Solutions Group in the year 2024?

In the year 2024, Advanced Medical Solutions Group distributed 0.022 GBP as dividends.

In which currency does Advanced Medical Solutions Group pay out the dividend?

The dividends of Advanced Medical Solutions Group are distributed in GBP.

All fundamentals about Advanced Medical Solutions Group

Our stock analysis for Advanced Medical Solutions Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Advanced Medical Solutions Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.